Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0036 | 1 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |